Thanks to updated screening methods and bioavailability enhancements, poorly soluble molecules comprise 70% to 80% of the small molecule products entering the drug development pipeline today. Since poorly soluble drugs are difficult to formulate as tablets, formulation scientists are looking to two-piece, liquid-filled hard-shell capsules as a solution.

Take this quiz to discover how much you know (or don’t know) about the benefits of using liquid-filled capsules in clinical trials.

By partnering with Altasciences, you can leverage our unique capabilities in the formulation, development, and manufacturing of drug products for small molecules. For more information on our industry-leading expertise in liquid-filled capsules: